N.-E. Ziraoui, M. Salazar, and A. Kensington, “BCLC™ NAD⁺ Supplement System Targeting SIRT1: A Time-Sequential Biphasic NMN-Resveratrol-Quercetin Formulation with Supporting Clinical and Pharmacological Evidence”, IJPHMR, vol. 6, no. 4, pp. 36–44, Apr. 2026, doi: 10.62051/ijphmr.v6n4.06.